Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, Lobeck H, Balzer T, del Tredici K, Neuhaus P, Felix R, Hammerstingl RM. Vogl TJ, et al. Among authors: balzer t. Eur Radiol. 2003 Feb;13(2):262-72. doi: 10.1007/s00330-002-1677-7. Epub 2002 Sep 10. Eur Radiol. 2003. PMID: 12598989 Clinical Trial.
Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient.
Hammerstingl R, Zangos S, Schwarz W, Rosen T, Bechstein WO, Balzer T, Vogl TJ. Hammerstingl R, et al. Among authors: balzer t. Acad Radiol. 2002 May;9 Suppl 1:S119-20. doi: 10.1016/s1076-6332(03)80415-4. Acad Radiol. 2002. PMID: 12019845 Clinical Trial. No abstract available.
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ; European EOB-study group. Hammerstingl R, et al. Among authors: balzer t. Eur Radiol. 2008 Mar;18(3):457-67. doi: 10.1007/s00330-007-0716-9. Epub 2007 Dec 6. Eur Radiol. 2008. PMID: 18058107
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R. Vogl TJ, et al. Among authors: balzer t. Radiology. 1996 Jul;200(1):59-67. doi: 10.1148/radiology.200.1.8657946. Radiology. 1996. PMID: 8657946 Clinical Trial.
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R. Vogl TJ, et al. Among authors: balzer jo, balzer t. Invest Radiol. 1996 Nov;31(11):696-708. doi: 10.1097/00004424-199611000-00004. Invest Radiol. 1996. PMID: 8915751 Clinical Trial.
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ; European EOB Study Group. Huppertz A, et al. Among authors: balzer t. Radiology. 2004 Jan;230(1):266-75. doi: 10.1148/radiol.2301020269. Radiology. 2004. PMID: 14695400 Clinical Trial.
61 results